Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ASB1-PPARG (FusionGDB2 ID:HG51665TG5468)

Fusion Gene Summary for ASB1-PPARG

check button Fusion gene summary
Fusion gene informationFusion gene name: ASB1-PPARG
Fusion gene ID: hg51665tg5468
HgeneTgene
Gene symbol

ASB1

PPARG

Gene ID

51665

5468

Gene nameankyrin repeat and SOCS box containing 1peroxisome proliferator activated receptor gamma
SynonymsASB-1CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma
Cytomap('ASB1')('PPARG')

2q37.3

3p25.2

Type of geneprotein-codingprotein-coding
Descriptionankyrin repeat and SOCS box protein 1peroxisome proliferator-activated receptor gammaPPAR-gammanuclear receptor subfamily 1 group C member 3peroxisome proliferator-activated nuclear receptor gamma variant 1
Modification date2020032720200329
UniProtAcc.

P37231

Ensembl transtripts involved in fusion geneENST00000469885, ENST00000264607, 
ENST00000409297, 
Fusion gene scores* DoF score7 X 5 X 5=17511 X 14 X 10=1540
# samples 723
** MAII scorelog2(7/175*10)=-1.32192809488736
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(23/1540*10)=-2.74322458463789
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: ASB1 [Title/Abstract] AND PPARG [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointASB1(239335760)-PPARG(12421203), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneASB1

GO:0016567

protein ubiquitination

16325183

TgenePPARG

GO:0000122

negative regulation of transcription by RNA polymerase II

12700342

TgenePPARG

GO:0006919

activation of cysteine-type endopeptidase activity involved in apoptotic process

18293083

TgenePPARG

GO:0007165

signal transduction

9568716

TgenePPARG

GO:0010742

macrophage derived foam cell differentiation

26504087

TgenePPARG

GO:0010745

negative regulation of macrophage derived foam cell differentiation

19114110

TgenePPARG

GO:0010871

negative regulation of receptor biosynthetic process

12700342

TgenePPARG

GO:0010887

negative regulation of cholesterol storage

19114110

TgenePPARG

GO:0010891

negative regulation of sequestering of triglyceride

12700342

TgenePPARG

GO:0016525

negative regulation of angiogenesis

28566713

TgenePPARG

GO:0030224

monocyte differentiation

9568716

TgenePPARG

GO:0032526

response to retinoic acid

16239304

TgenePPARG

GO:0042953

lipoprotein transport

9568716

TgenePPARG

GO:0043537

negative regulation of blood vessel endothelial cell migration

28566713

TgenePPARG

GO:0045713

low-density lipoprotein particle receptor biosynthetic process

9568716

TgenePPARG

GO:0045944

positive regulation of transcription by RNA polymerase II

9568715|12700342|16239304|17611579

TgenePPARG

GO:0048469

cell maturation

9568716

TgenePPARG

GO:0048662

negative regulation of smooth muscle cell proliferation

20622039

TgenePPARG

GO:0051091

positive regulation of DNA-binding transcription factor activity

18293083

TgenePPARG

GO:0061614

pri-miRNA transcription by RNA polymerase II

28566713

TgenePPARG

GO:0071404

cellular response to low-density lipoprotein particle stimulus

9568716

TgenePPARG

GO:1904706

negative regulation of vascular smooth muscle cell proliferation

28522568



check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4STADTCGA-BR-A4QI-01AASB1chr2

239335760

+PPARGchr3

12421203

+


Top

Fusion Gene ORF analysis for ASB1-PPARG

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
3UTR-5UTRENST00000469885ENST00000287820ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000309576ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000397000ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000397010ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000397012ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000397015ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000397026ASB1chr2

239335760

+PPARGchr3

12421203

+
3UTR-5UTRENST00000469885ENST00000539812ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000287820ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000309576ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000397000ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000397010ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000397012ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000397015ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000397026ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000264607ENST00000539812ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000287820ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000309576ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000397000ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000397010ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000397012ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000397015ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000397026ASB1chr2

239335760

+PPARGchr3

12421203

+
5CDS-5UTRENST00000409297ENST00000539812ASB1chr2

239335760

+PPARGchr3

12421203

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ASB1-PPARG


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)
ASB1chr2239335760+PPARGchr312421202+6.07E-060.9999939
ASB1chr2239335760+PPARGchr312421202+6.07E-060.9999939


check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.
genomic feature of top 1%

Top

Fusion Protein Features for ASB1-PPARG


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:239335760/:12421203)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
.PPARG

P37231

FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity). {ECO:0000250|UniProtKB:P37238, ECO:0000269|PubMed:16150867, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:9065481}.; FUNCTION: (Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein. {ECO:0000269|PubMed:25504154}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ASB1-PPARG


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ASB1-PPARG


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ASB1-PPARG


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
TgenePPARGP37231DB00244MesalazineAgonistSmall moleculeApproved
TgenePPARGP37231DB00244MesalazineAgonistSmall moleculeApproved
TgenePPARGP37231DB00573FenoprofenSmall moleculeApproved
TgenePPARGP37231DB00573FenoprofenSmall moleculeApproved
TgenePPARGP37231DB00795SulfasalazineAgonistSmall moleculeApproved
TgenePPARGP37231DB00795SulfasalazineAgonistSmall moleculeApproved
TgenePPARGP37231DB01050IbuprofenActivatorSmall moleculeApproved
TgenePPARGP37231DB01050IbuprofenActivatorSmall moleculeApproved
TgenePPARGP37231DB02266Flufenamic acidAgonistSmall moleculeApproved
TgenePPARGP37231DB02266Flufenamic acidAgonistSmall moleculeApproved
TgenePPARGP37231DB13873Fenofibric acidSmall moleculeApproved
TgenePPARGP37231DB13873Fenofibric acidSmall moleculeApproved
TgenePPARGP37231DB11672CurcuminSmall moleculeApproved|Experimental|Investigational
TgenePPARGP37231DB11672CurcuminSmall moleculeApproved|Experimental|Investigational
TgenePPARGP37231DB00313Valproic acidSmall moleculeApproved|Investigational
TgenePPARGP37231DB00313Valproic acidSmall moleculeApproved|Investigational
TgenePPARGP37231DB00328IndomethacinActivatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB00328IndomethacinActivatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB00412RosiglitazoneAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00412RosiglitazoneAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00731NateglinideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00731NateglinideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00845ClofazimineModulatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB00845ClofazimineModulatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB00912RepaglinideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00912RepaglinideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00966TelmisartanPartial agonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB00966TelmisartanPartial agonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01014BalsalazideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01014BalsalazideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01067GlipizideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01067GlipizideAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01118AmiodaroneAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01118AmiodaroneAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01132PioglitazoneAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01132PioglitazoneAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01393BezafibrateAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB01393BezafibrateAgonistSmall moleculeApproved|Investigational
TgenePPARGP37231DB03756DoconexentLigandSmall moleculeApproved|Investigational
TgenePPARGP37231DB03756DoconexentLigandSmall moleculeApproved|Investigational
TgenePPARGP37231DB08604TriclosanSmall moleculeApproved|Investigational
TgenePPARGP37231DB08604TriclosanSmall moleculeApproved|Investigational
TgenePPARGP37231DB09061CannabidiolActivatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB09061CannabidiolActivatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB09213DexibuprofenActivatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB09213DexibuprofenActivatorSmall moleculeApproved|Investigational
TgenePPARGP37231DB00132alpha-Linolenic acidSmall moleculeApproved|Investigational|Nutraceutical
TgenePPARGP37231DB00132alpha-Linolenic acidSmall moleculeApproved|Investigational|Nutraceutical
TgenePPARGP37231DB04224Oleic AcidLigandSmall moleculeApproved|Investigational|Vet_approved
TgenePPARGP37231DB04224Oleic AcidLigandSmall moleculeApproved|Investigational|Vet_approved
TgenePPARGP37231DB00197TroglitazoneAgonistSmall moleculeApproved|Investigational|Withdrawn
TgenePPARGP37231DB00197TroglitazoneAgonistSmall moleculeApproved|Investigational|Withdrawn
TgenePPARGP37231DB00159IcosapentAgonistSmall moleculeApproved|Nutraceutical
TgenePPARGP37231DB00159IcosapentAgonistSmall moleculeApproved|Nutraceutical
TgenePPARGP37231DB11133Omega-3 fatty acidsLigandSmall moleculeApproved|Nutraceutical
TgenePPARGP37231DB11133Omega-3 fatty acidsLigandSmall moleculeApproved|Nutraceutical
TgenePPARGP37231DB13961Fish oilBiotechApproved|Nutraceutical
TgenePPARGP37231DB13961Fish oilBiotechApproved|Nutraceutical

Top

Related Diseases for ASB1-PPARG


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneC0011860Diabetes Mellitus, Non-Insulin-Dependent6CTD_human;GENOMICS_ENGLAND
TgeneC0238463Papillary thyroid carcinoma4ORPHANET
TgeneC0002152Alloxan Diabetes3CTD_human
TgeneC0002395Alzheimer's Disease3CTD_human
TgeneC0011265Presenile dementia3CTD_human
TgeneC0011853Diabetes Mellitus, Experimental3CTD_human
TgeneC0020538Hypertensive disease3CTD_human
TgeneC0021655Insulin Resistance3CTD_human
TgeneC0022660Kidney Failure, Acute3CTD_human
TgeneC0028754Obesity3CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneC0035126Reperfusion Injury3CTD_human
TgeneC0038433Streptozotocin Diabetes3CTD_human
TgeneC0276496Familial Alzheimer Disease (FAD)3CTD_human
TgeneC0494463Alzheimer Disease, Late Onset3CTD_human
TgeneC0546126Acute Confusional Senile Dementia3CTD_human
TgeneC0750900Alzheimer's Disease, Focal Onset3CTD_human
TgeneC0750901Alzheimer Disease, Early Onset3CTD_human
TgeneC0920563Insulin Sensitivity3CTD_human
TgeneC1565662Acute Kidney Insufficiency3CTD_human
TgeneC1720861Familial Partial Lipodystrophy, Type 33CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneC2609414Acute kidney injury3CTD_human
TgeneC0021368Inflammation2CTD_human
TgeneC0022116Ischemia2CTD_human
TgeneC0024623Malignant neoplasm of stomach2CTD_human
TgeneC0025202melanoma2CTD_human
TgeneC0030297Pancreatic Neoplasm2CTD_human
TgeneC0038356Stomach Neoplasms2CTD_human
TgeneC0346647Malignant neoplasm of pancreas2CTD_human
TgeneC1708349Hereditary Diffuse Gastric Cancer2CTD_human
TgeneC0001418Adenocarcinoma1CTD_human
TgeneC0004153Atherosclerosis1CTD_human
TgeneC0004763Barrett Esophagus1CTD_human
TgeneC0007102Malignant tumor of colon1CTD_human;UNIPROT
TgeneC0009375Colonic Neoplasms1CTD_human
TgeneC0009402Colorectal Carcinoma1CTD_human
TgeneC0009404Colorectal Neoplasms1CTD_human
TgeneC0010346Crohn Disease1CTD_human
TgeneC0011849Diabetes Mellitus1CTD_human
TgeneC0011859Lipoatrophic Diabetes Mellitus1ORPHANET
TgeneC0011881Diabetic Nephropathy1CTD_human
TgeneC0017658Glomerulonephritis1CTD_human
TgeneC0017667Nodular glomerulosclerosis1CTD_human
TgeneC0018801Heart failure1CTD_human
TgeneC0018802Congestive heart failure1CTD_human
TgeneC0023212Left-Sided Heart Failure1CTD_human
TgeneC0023645Lichen planus follicularis1GENOMICS_ENGLAND
TgeneC0023794Lipoidosis1CTD_human
TgeneC0023903Liver neoplasms1CTD_human
TgeneC0025517Metabolic Diseases1CTD_human
TgeneC0027746Nerve Degeneration1CTD_human
TgeneC0029408Degenerative polyarthritis1CTD_human
TgeneC0030246Pustulosis of Palms and Soles1CTD_human
TgeneC0030625Passive Cutaneous Anaphylaxis1GENOMICS_ENGLAND
TgeneC0033860Psoriasis1CTD_human
TgeneC0035078Kidney Failure1CTD_human
TgeneC0038525Subarachnoid Hemorrhage1CTD_human
TgeneC0040136Thyroid Neoplasm1CTD_human
TgeneC0079772T-Cell Lymphoma1CTD_human
TgeneC0085278Antiphospholipid Syndrome1CTD_human
TgeneC0085413Polycystic Kidney, Autosomal Dominant1CTD_human
TgeneC0086743Osteoarthrosis Deformans1CTD_human
TgeneC0086873Pseudopelade1GENOMICS_ENGLAND
TgeneC0151468Thyroid Gland Follicular Adenoma1CTD_human
TgeneC0156147Crohn's disease of large bowel1CTD_human
TgeneC0205641Adenocarcinoma, Basal Cell1CTD_human
TgeneC0205642Adenocarcinoma, Oxyphilic1CTD_human
TgeneC0205643Carcinoma, Cribriform1CTD_human
TgeneC0205644Carcinoma, Granular Cell1CTD_human
TgeneC0205645Adenocarcinoma, Tubular1CTD_human
TgeneC0206726gliosarcoma1ORPHANET
TgeneC0221032Familial generalized lipodystrophy1ORPHANET
TgeneC0221406Pituitary-dependent Cushing's disease1CTD_human
TgeneC0235527Heart Failure, Right-Sided1CTD_human
TgeneC0236811Chronobiology Disorders1CTD_human
TgeneC0242339Dyslipidemias1CTD_human
TgeneC0242488Acute Lung Injury1CTD_human
TgeneC0267380Crohn's disease of the ileum1CTD_human
TgeneC0270192Perinatal Subarachnoid Hemorrhage1CTD_human
TgeneC0271694Familial partial lipodystrophy1CTD_human
TgeneC0282548Leukostasis1CTD_human
TgeneC0334588Giant Cell Glioblastoma1ORPHANET
TgeneC0345904Malignant neoplasm of liver1CTD_human
TgeneC0472383Subarachnoid Hemorrhage, Spontaneous1CTD_human
TgeneC0525045Mood Disorders1PSYGENET
TgeneC0549473Thyroid carcinoma1CTD_human
TgeneC0598784Dyslipoproteinemias1CTD_human
TgeneC0678202Regional enteritis1CTD_human
TgeneC0751220Inappropriate ACTH Secretion Syndrome1CTD_human
TgeneC0751530Subarachnoid Hemorrhage, Aneurysmal1CTD_human
TgeneC0795688Subarachnoid Hemorrhage, Intracranial1CTD_human
TgeneC0813142Circadian Rhythm Disorders1CTD_human
TgeneC0887800Psychogenic Inversion of Circadian Rhythm1CTD_human
TgeneC0887850Polycystic Kidney, Type 1 Autosomal Dominant Disease1CTD_human
TgeneC0949272IIeocolitis1CTD_human
TgeneC1258085Barrett Epithelium1CTD_human
TgeneC1563937Atherogenesis1CTD_human
TgeneC1565489Renal Insufficiency1CTD_human
TgeneC1704377Bright Disease1CTD_human
TgeneC1720859Familial Partial Lipodystrophy, Type 11CTD_human
TgeneC1720860Familial Partial Lipodystrophy, Type 21CTD_human
TgeneC1959583Myocardial Failure1CTD_human
TgeneC1961112Heart Decompensation1CTD_human
TgeneC2239176Liver carcinoma1CTD_human
TgeneC2751306Polycystic kidney disease, type 21CTD_human
TgeneC2931367Thyroid cancer, follicular1CTD_human
TgeneC2936846Scarring alopecia1GENOMICS_ENGLAND